Epidermal growth factor-dependent cell cycle progression is altered in mammary epithelial cells that overexpress c-myc

Clinical Cancer Research

Volumn 4, Issue 7, 1998, Pages 1813-1822

  Nass, Sharyl J ^a,b   Dickson, Robert B ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; TRANSFORMING GROWTH FACTOR ALPHA;

ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER GROWTH; CARCINOGENESIS; CELL CYCLE; ENZYME ACTIVATION; FEMALE; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; ONCOGENE C MYC; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ANIMALS; BREAST; CELL CYCLE; CELL DIVISION; CELL LINE, TRANSFORMED; CYCLIN-DEPENDENT KINASES; EPIDERMAL GROWTH FACTOR; FEMALE; G1 PHASE; HUMANS; MAMMARY GLANDS, ANIMAL; MICE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-MYC; RETINOBLASTOMA PROTEIN; S PHASE; TUMOR CELLS, CULTURED;

EID: 0031745801     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Marcu, K. B., Bossone, S. A., and Patel, A. J. Myc function and regulation. Annu. Rev. Biochem., 61: 809-850, 1992.
2. Meichle, A., Philipp, A., and Eilers, M. The functions of the Myc proteins. Biochim. Biophys. Acta, 1114: 129-146, 1992.
3. Henriksson, M., and Luscher, B. Proteins of the Myc network: essential regulators of cell growth and differentiation. Adv. Cancer Res., 68: 109-182, 1996.
4. Ryan K. M., and Birnie G. D. Myc oncogenes: the enigmatic family. Biochem. J., 314: 713-721, 1996.
5. Packham, G., and Cleveland, J. L. c-Myc and apoptosis. Biochim. Biophys. Acta, 1242: 11-28, 1995.
6. Amati, B., and Land, H. Myc-Max-Mad: a transcription factor network controlling cell cycle progression, differentiation and death. Curr. Opin. Genet. Dev., 4; 102-108, 1994.
7. Morgenbesser, S. D., and DePinho, R. A. Use of transgenic mice to study myc family gene function in normal mammalian development and in cancer. Semin. Cancer Biol., 5: 21-36, 1994.
8. Kelly, K., and Siebenlist, U. The regulation and expression of c-myc in normal and malignant cells. Annu. Rev. Immunol., 4: 317-338, 1986.
9. Hanson, K. D., Shichiri, M., Follansbee, M. R., and Sedivy, J. M. Effects of c-myc expression on cell cycle progression. Mol. Cell. Biol., 14: 5748-5755, 1994.
10. 1. Nature (Lond.), 328: 445-449, 1987.
11. 1 progression in murine erythroleukemia cells. Mol. Cell. Biol., 8: 3683-3695, 1988.
12. Karn, J., Watson, J. V., Lowe, A. D., Green, S. M., and Vedeckis, W. Regulation of cell cycle duration by c-myc levels. Oncogene, 4: 773-787, 1989.
13. Eilers, M., Schirm, S., and Bishop, M. J. The Myc protein activates transcription of the α-prothymosin gene. EMBO J., 10: 133-141, 1991.
14. Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C. M., Penn, L. Z., and Hancock, D. C. Induction of apoptosis in fibroblasts by c-myc protein. Cell, 69: 119-128, 1992.
15. 1 phase progression: cycling on cue. Cell, 79: 551-555, 1994.
16. Jansen-Durr, P., Meichle, A., Steiner, P., Pagano, M., Finke, K., Botz, J., Wessbecher, J., Draetta, G., and Eilers, M. Differential modulation of cyclin gene expression by MYC. Proc. Natl. Acad. Sci. USA, 90: 3685-368, 1993.
17. Hoang, A. T., Cohen, K. J., Barrett, J. F., Bergstrom, D. A., and Dang, C. V. Participation of cyclin A in Myc-induced apoptosis. Proc. Natl. Acad. Sci. USA, 91: 6875-6879, 1994.
18. Daksis, J. I., Lu, R. Y., Facchini, L. M., Marhin, W. W., and Penn, L. Z. Myc induces cyclin D1 expression in the absence of de novo protein synthesis and links mitogen-stimulated signal transduction to the cell cycle. Oncogene, 9: 3635-3645, 1994.
19. cdc2 and cyclin-dependent kinase-2 in T lymphocytes. J. Immunol., 152: 4328-4334, 1994.
20. Born, T. L., Frost, J. A., Schonthal, A., Prendergast, G. C., and Feramisco, J. R. c-Myc cooperates with activated ras to induce the cdc2 promoter. Mol. Cell. Biol., 14: 5710-5718, 1994.
21. 1 cyclin-cdk complexes. EMBO J., 14: 4814-4826, 1995.
22. Galaktionov, K., Chen, X., and Beach, D. Cdc25 cell-cycle phosphatase as a target of c-myc. Nature (Lond.), 382: 511-517, 1996.
23. Nass, S. J., and Dickson, R. B. Defining a role for c-Myc in breast tumorigenesis. Breast Cancer Res. Treat., 44: 1-22, 1997.
24. Amundadottir, L. T., Johnson, M. D., Merlino, G., Smith, G., and Dickson, R. B. Synergistic interaction of transforming growth factor α and c-myc in mouse mammary and salivary gland tumorigenesis. Cell Growth Differ., 6: 737-748, 1995.
25. Sandgren, E. P., Schroeder, J. A., Qui, T. H., Palmiter, R. D., Brinster, R. L., and Lee, D. C. Inhibition of mammary gland involution is associated with TGFα- but not c-myc-induced tumorigenesis in transgenic mice. Cancer Res., 55: 3915-3927, 1995.
26. Derynck, R., Goeddel, D. V., Ullrich, A., Gutterman, J. U., Williams, R. D., Bringman, T. S., and Berger, W. H. Synthesis of messenger RNAs for transforming growth factors α and β and the epidermal growth factor receptor by human tumors. Cancer Res., 47: 707-712, 1987.
27. Travers, M. T., Barrett-Lee, P. J., Berger, U., Luqmani, Y. A., Gazet, J. C., Powles, T. J., and Coombes, R. C. Growth factor expression in normal, benign, and malignant breast tissue. Br. Med. J., 296: 1621-1624, 1988.
28. Telang, N. T., Osborne, M. P., Sweterlitsch, L. A., and Narayanan, R. Neoplastic transformation of mouse mammary epithelial cells by deregulated myc expression. Cell Regul., 1: 863-872, 1990.
29. Valverius, E. M., Ciardiello, F., Heldin, N. E., Blondel, B., Merlino, G., Smith, G., Stampfer, M. R., Lippman, M. E., Dickson, R. B., and Salomon, D. S. Stromal influences on transformation of human mammary epithelial cells overexpressing c-myc and SV40T. J. Cell. Physiol., 145: 207-216, 1990.
30. Amundadottir, L. T., Nass, S. J., Berchem, G., Johnson, M. D., and Dickson, R. B. Cooperation of TGFα and c-Myc in mouse mammary tumorigenesis: coordinated stimulation of growth and suppression of apoptosis. Oncogene, 13: 757-765, 1996.
31. L in the regulation of apoptosis by EGF and TGFβ1 in c-Myc overexpressing mammary epithelial cells. Biochem. Biophys. Res. Commun., 227: 248-256, 1996.
32. Sweeney, K. J. E., Musgrove, E. A., Watts, C. K. W., and Sutherland, R. L. Cyclins and breast cancer. In: R. B. Dickson and M. E. Lippman (eds.), Mammary Tumor Cell Cycle, Differentiation and Metastasis, pp. 141-170. Boston: Kluwer Academic Publishers, 1996.
33. Stampfer, M. R., and Bartley, J. C. Human mammary epithelial cells in culture: differentiation and transformation. In:M. E. Lippman and R. B. Dickson (eds.). Breast Cancer: Cellular and Molecular Biology, pp. 1-24. Boston: Kluwer Academic Publishers, 1988.
34. Stampfer, M. R., Pan, C. H., Hosoda, J., Bartholomew, J., Mendelsohn, J., and Yaswen, P. Blockage of EGF receptor signal transduction causes reversible arrest of normal and immortal human mammary epithelial cells with synchronous reentry into the cell cycle. Exp. Cell Res., 205: 175-188, 1993.
35. Ball, R. K., Ziemiecki, A., Schonenberger, C. A., Reichmann, E., Redmond, S. M. S., and Groner, B. V-myc alters the response of a cloned mouse mammary epithelial cell line to lactogenic hormones. Mol. Endocrinol., 2: 133-142, 1988.
36. Fransden, T. L., Boysen, B. E., Jirus, S., Spang-homsen, M., Dano K., Thompson, E. W., and Brunner, N. Experimental models for the study of human cancer cell invasion and metastasis. Fibrinolysis, 6 (Suppl. 4): 71-76, 1992.
37. Vindelov, L. L., Christensen, I. J., and Nissen, N. I. A detergenttrypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry, 3: 323-327, 1983.
38. Chomzynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
39. Nass, S. J., and Dickson, R. B. Detection of cyclin messenger RNA by non-radioactive RNase protection assay: a comparison of four detection systems. BioTechniques, 19: 772-778, 1995.
40. Morgan, D. O. Principles of CDK regulation. Nature (Lond.), 374: 131-134, 1995.
41. Weinberg, R. A. The retinoblastoma protein and cell cycle control. Cell, 81: 323-330, 1995.
42. Hatakeyama, M., Brill, J. A., Fink, G. R., and Weinberg, R. A. Collaboration of G1 cyclins in the functional inactivation of the retinoblastoma protein. Genes Dev., 8: 1759-1771, 1994.
43. Hinds, P. W., Mittnacht, S., Dulic, V., Arnold, A., Reed, S. I., and Weinberg, R. A. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell, 70: 993-1006, 1992.
44. Kato, J. Y., Matsushime, J-Y., Hiebert, S. W., Ewen, M. E., and Sherr, C. J. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev., 7: 331-342, 1993.
45. Meyerson, M., and Harlow, E. Identification of G1 kinase activity of cdk6, a novel cyclin D partner. Mol. Cell. Biol., 14: 2077-2086, 1994.
46. 1-to-S transition. Mol. Cell. Biol., 15: 3463-3469, 1995.
47. Akiyama, T., Ohuchi, T., Sumida, S., Matsumoto, K., and Toyoshima, K. Phosphorylation of the retinoblastoma protein by cdk2. Proc. Natl. Acad. Sci. USA, 89: 7900-7904, 1992.
48. 1 phase of the human cell cycle. Science (Washington DC), 257: 1689-1694, 1992.
49. Koff, A., Cross, F., Fisher, A., Schumacher, J., Leguellec, K., Phillipe, M., and Robert, J. M. Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family. Cell, 66: 1217-1228, 1991.
50. Lew, D. J., Dulic, V., and Reed, S. I. Isolation of three novel human cyclins by rescue of G1 cyclin (Cln) function in yeast. Cell, 66: 1197-1206, 1991.
51. Lundeberg, A. S., and Weinberg, R. A. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol. Cell Biol., 18: 753-761, 1998.
52. 1 restriction point regulation in Rb-deficient fibroblasts. Mol. Cell. Biol., 16: 2402-2407, 1996.
53. Roussel, M. F., Thedoras, A. M., Pagano, M., and Sherr, C. J. Rescue of defective mitogenic signaling by D-type cyclins. Proc. Natl. Acad. Sci. USA, 92: 6837-6841, 1995.
54. Kwon, T. K., Buchholz, M. A., Gabrielson, E. W., and Nordin, A, A. A novel cytoplasmic substrate for cdk4 and cdk6 in normal and malignant epithilial derived cells. Oncogene, 11: 2077-2083, 1995.
55. Hengst, L., and Reed, S. I. Translational control of p27Kip1 accumulation during the cell cycle. Science (Washington DC), 271: 1861-1864, 1996.
56. Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev., 8: 9-22, 1994.
57. Slingerland, J. M., Hengst, L., Pan, C. H., Alexander, D., Stampfer, M. R., and Reed, S. I. A novel inhibitor of cyclin-cdk activity detected in transforming growth factor β-arrested epithelial cells. Mol. Cell. Biol., 14: 3683-3694, 1994.
58. Kip1 is abrogated by c-Myc. EMBO J., 15: 6595-6604, 1996.
59. Galaktionov, K., Lee, A. K., Eckstein, J., Draetta, G., Meckler, J., Loda, M., and Beach, D. CDC25 phosphatases as potential human oncogenes. Science (Washington DC), 269: 1575-1577, 1995.
60. Galaktionov, K., Jessus, C., and Beach, D. Raf1 interaction with Cdc25 phosphatase ties mitogenic signal transduction to cell cycle activation. Genes Dev., 9: 1046-1058, 1995.
61. Rudolph, B., Saffrich, R., Zwicker, J., Henglein, B., Muller, R., Ansorge, W., and Eilers, M. Activation of cyclin-dependent kinases by Myc mediates induction of cyclin A, but not apoptosis. EMBO J., 15: 3065-3076, 1996.
62. Dickson, R. B., and Lippman, M. E. Growth factors in breast cancer. Endocr. Rev., 16: 559-589, 1995.
63. Yin, Y., Tainsky, M. A., Bischoff, F. Z., Strong, L. C., and Wahl, G. M. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell, 70: 937-948, 1992.
64. Livingstone, L. R., White, A., Sprouse, J., Livanos, E., Jacks, T., and Tlsty, T. D. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell, 70: 923-935, 1992.
65. Mai, S., Fluri, M., Siwarski, D., and Huppi, K. Genomic instability in MycER-activated Rat1a-MycER cells. Chromosome Res., 4: 365-371, 1996.
66. Chernova, O. B, Chernov, M. V., Ishizaka, Y., Agarwal, M. L., and Stark, G. R. MYC abrogates p53-mediated cell cycle arrest in N-(phosphonacetyl-L-aspartate-treated cells, permitting CAD gene amplification. Mol. Cell. Biol., 18: 536-545, 1998.